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Bone or soft tissue sarcomas are rarely diagnosed during pregnancy. Until today 137 well doc-
umented cases have been reported in the English literature between 1963 and 2014. Thirty-eight
pregnant mothers were diagnosed with osteosarcoma, Ewing’s sarcoma or chondrosarcoma,
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Hospital, Athens, Greewhereas 95 other cases of soft tissue sarcomas of various types have been documented. We pre-
sent the clinical picture and therapeutic management of this coexistence.
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Cancer and pregnancy
Cancer diagnosis during pregnancy is a rare coexistence in a
ratio of one case per 1000 deliveries. However, there is an
increasing trend due to delaying pregnancy in western societies
into the later reproductive years [1].
The most common gestational cancers are those appearing
during the reproductive period of a woman. Breast cancer and
cervical cancers are the most frequently diagnosed malignan-
cies followed by hematological tumors and melanoma [1].
Diagnostic and staging workup should be very carefully
performed due to maternal and fetal radiation exposure. Rec-
ommendation of imaging studies should always follow the
established guidelines [2].
Systemic chemotherapy should be avoided during the first
trimester of pregnancy due to lethal, teratogenic or develop-
mental malformation effects. However, during the second
and third trimesters certain chemotherapeutic drugs can be
administered. Hormonal and/or targeted treatments should
not be advised. In addition, radiotherapy cannot be applied
to the mother’s trunk due to the lethal effects on the fetus [3,4].
Metastatic transmission to the products of conception hap-
pens rarely and the most frequent malignancies that invade
placenta and fetus are melanoma (30%), cancer of unknown
primary site (22.5%), hematological malignancies (15%),
breast cancer (14%) and lung cancer (13%) [5].
Bone and soft tissue sarcomas [6]
Malignant bone tumors are rare, accounting for only 0.2% of
all malignancies. Among them the most frequent are osteosar-
coma, Ewing’s sarcoma and chondrosarcoma. Less frequent
sarcomas are the malignant fibrous histiocytoma, chordoma,
and very rarely liposarcoma, angiosarcoma, and
hemangiopericytoma.
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It is the commonest primary bone tumor and occurs predom-
inantly in adolescence with a peak incidence at the age of 15–
19 years. Osteosarcoma most commonly involves long bones
(mainly the tibia close to knee joint) and more rarely the axial
skeleton. It presents with localized bone pain characteristically
during the night or at rest. Limb-sparing surgery with extend-
ing endoprostheses is the treatment of choice. Adjuvant
chemotherapy improves overall survival. In certain cases
neoadjuvant chemotherapy can be used.
Ewing’s sarcoma
It is part of the Ewing’s sarcoma family including also the
primitive neuroendocrine tumor and Askin’s tumor. The med-
ian age is 14 years and tumor affects long bones or axial skele-
ton. Presenting symptoms are local pain, (deteriorating at
night) as well as fever or weight loss. Systemic chemotherapy
(neoadjuvant or adjuvant) is usually followed by local radio-
therapy. In certain cases, surgery can be recommended follow-
ing induction chemotherapy.
Chondrosarcoma
It is more commonly diagnosed over the age of 40. Most fre-
quently it affects the pelvis, axial skeleton and proximal limbs.
Histologic grading is important ranging from grade 1 to 3. The
primary modality of therapy is surgery. Five-year survival is
>90% and 25% for grade 1 and 3, respectively.
Soft tissue sarcomas
Leiomyosarcoma
The most common site of leiomyosarcomas is the retroperi-
toneum (50%), followed by abdominal viscera, uterus or
extremities. Retroperitoneal leiomyosarcomas usually present
with vague abdominal discomfort, abdominal mass or weight
loss, while peripherally located primaries present with a pain-
less enlarging mass. Surgery remains the dominant treatment.
Chemotherapy has poor results in metastatic disease.
Liposarcoma
It affects adults between 40 and 60. It involves most commonly
the thigh followed by abdominal cavity. Histologically, there
are four types: well-differentiated, myxoid, pleomorphic and
dedifferentiated liposarcoma. Prognosis is dependent on histo-
logic type and site of disease.
Rhabdomyosarcoma
They arise from skeletal muscle cells. The most common loca-
tions are in the head and neck (40%), the genitourinary tract
(25%) and the extremities (20%). The symptoms are associ-
ated with the tumor location. There are two main histologic
types: the embryonic and the alveolar type.
GIST (Gastrointestinal stromal tumors)
GISTs are soft tissue mesenchymal tumors occurring in the
gastrointestinal tract, originating in the interstitial cells ofCajal. The annual incidence in UK ranges from 1.32 to 1.50
per 100,000 population which is equivalent to 800–900 new
cases per year. The stomach (60%) and small intestine (30%)
are the most common primary sites followed by duodenum
(5%) and colorectum (5%). The most common symptoms
are vague, nonspecific abdominal pain and discomfort. Rarely
GI obstruction or bleeding could be seen.
Surgery is the primary treatment, whereas targeted therapy
with tyrosine kinase inhibitors (imatinib, sunitinib or rego-
rafenib) produced excellent results in both adjuvant and meta-
static settings.
Synovial sarcoma
It can occur at any age but it is more common among teen-
agers and young adults. Most commonly it is located in the
legs or arms. It is usually diagnosed as a slowly growing pain-
less mass. Surgery followed by radiotherapy is the recom-
mended treatment. Chemotherapy is advised in patients with
metastatic disease.
Kaposi’s sarcoma
Is a sarcoma caused by human herpesvirus 8. It is classified
into four different forms: the classic, the endemic, the immuno-
suppression – associated and AIDS-associated Kaposi sarco-
mas. It involves the skin, mouth, GI tract and respiratory
tract. In general, surgery is not recommended.
Angiosarcoma
It most commonly occurs in the skin, breast, liver, spleen and
deep tissue. It can present as a skin lesion or a painless soft
lump. Surgery is the primary therapeutic choice.
Endometrial stromal sarcoma (EDS)
EDSs are very rare malignant tumors that make up approxi-
mately 10% of uterine sarcomas but only around 0.2% of all
uterine sarcomas. They can present by abnormal bleeding or
spotting, vaginal discharge, pelvic pain or mass. Histologically,
EDSs are divided into the following: (a) endometrial stromal
nodule, (b) low-grade endometrial stromal sarcoma and (c)
undifferentiated stromal sarcoma. Surgery with adjuvant
radiotherapy is the recommended treatment. Five-year sur-
vival for early stage I is 54–100%, for stage II (30%) and for
stage III–IV only 11%.
Literature search
Bone sarcomas (Table 1)
Osteosarcoma
In total 24 cases of various subtypes of gestational osteosarco-
mas have been reported since 1977. Osteoblastic, fibroblastic,
chondroblastic, paraostal or high-grade osteosarcomas have
been documented. The most common primary bone sites were
thigh, pelvis and back, whereas the most frequent presenting
symptoms were pain, detection of a mass or pathological frac-
ture. Most patients were treated surgically either during
Table 2 Soft tissue sarcomas during pregnancy.
Histology No of cases % (all sarcomas)a Period
Leiomyosarcoma [9,21–34] 17 12 1969–2010
Liposarcoma [10,29,35–43] 17 12 1993–2014
Rhabdomyosarcoma [10,44–56] 14 10 1969–2014
GIST (57–65)b 9 7 1996–2014
Synovial sarcoma [29,66–72] 9 7 2007–2014
Kaposi’s sarcoma [73–80] 8 6 1971–2012
Angiosarcoma [9,81–83] 5 4 2004–2013
Endometrial stromal sarcoma [84–88] 5 4 2002–2014
a Out of a total of 137 sarcomas reported.
b Gastrointestinal stromal tumors.
Table 1 Bone sarcomas during pregnancy.
Histology No of cases % (all sarcomas)a Period
Osteosarcoma [7–12] 24 17 1977–2012
Ewing’s sarcoma [10,13–18] 19 14 1963–2012
Chondrosarcoma [9,10,19,20] 10 7 1989–2015
a Out of a total of 137 sarcomas reported.
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chemotherapy in an adjuvant setting during the postpartum
period. Survival outcomes are similar to their nonpregnant
counterparts [7–12].
Ewing’s sarcoma
Since 1963 19 cases of gestational Ewing’s sarcomas have been
published in the English literature, including three cases of
extra-skeletal Ewing’s sarcoma. Almost all cases were diag-
nosed during pregnancy. Most cases were treated during preg-
nancy with chemotherapy, radiotherapy to the extremity and/
or surgery and resulted in a favorable outcome for both
mother and newborn. Only two patients underwent termina-
tion of pregnancy [10,13–18].
Chondrosarcoma
Only 10 cases of gestational chondrosarcomas appeared in the
literature during the last 25 years. Primary tumors were
located on iliac, innominate, tibial head and maxillary bones.
One case was diagnosed as extraskeletal myxoid chondrosar-
coma. Surgical intervention during pregnancy is not always
feasible [9,10,19,20].
Soft tissue sarcomas (Table 2)
Leiomyosarcoma
Gestational leiomyosarcoma constitutes 12% of all sarcomas
diagnosed during pregnancy. Since 1969, 17 cases have
appeared in the literature. Among the reported cases most of
them arise in the uterus followed by vulva, jejunum and
retroperitoneal area. Histopathologically, typical leiomyosar-
comas (mostly high grade), or epithelioid or myxoid type
was diagnosed. Uterine leiomyosarcomas are generally consid-
ered to be more aggressive than other types of uterine tumors
[9,21–34].Liposarcoma
During the last two decades 17 cases of liposarcomas during
pregnancy (12%) have been published. Almost all of them
were located in the retroperitoneal area mostly with myxoid
histology. Surgical manipulation is not feasible in all patients.
About 50% of patients died early after diagnosis, while new-
borns remained well and healthy wherever deliveries were
achievable [10,29,35–43].
Rhabdomyosarcoma
Fourteen cases of gestational rhabdomyosarcoma (10%) have
been described during the last 45 years. Most common primary
sites were orbit or vagina followed by maxillary sinus, nasal
septum, perineum, bladder, breast or retroperitoneum. Apart
from typical rhabdomyosarcomas some patients were diag-
nosed with embryonal, botryoid, spindle-cell or alveolar sub-
type of rhabdomyosarcomas. In one case invasion of the
placenta was found [10,44–56].
Gastrointestinal stromal sarcoma (GIST)
Since the term of GIST was given in 1983, 9 pregnant mothers
with gestational GIST have been documented. Signs and
symptoms are usually non-specific unless they occur as a result
of the ‘‘mass effect” of the tumor itself. CT scans are not rec-
ommended, however they can be replaced by abdominal ultra-
sound or even MRI. The optimal timing of surgery it is not
well defined leaving the decision to the multidisciplinary team
setting although it is considered safe in pregnancy. Imatinib
treatment during pregnancy or breast feeding is contra-
indicated since spontaneous miscarriages and birth defects
have been reported. Prognosis of women with gestational
GIST remains favorable [57–65].
Synovial sarcomas
Gestational synovial sarcomas are rare sarcomas. Since 2007
only 9 cases (7%) of synovial sarcomas during pregnancy were
Bone and soft tissue sarcomas during pregnancy 585found. Three were primary pulmonary sarcomas, two head
and neck sarcomas, one leg, one pelvis, one abdominal wall
and one renal synovial sarcoma. Signs and symptoms included
local slowly growing swelling for superficial tumors or symp-
toms related to the primary sites i.e. dyspnea, hematuria. Most
women died of advanced disease [29,66–72].
Kaposi’s sarcoma
Eight cases (6%) of Kaposi’s sarcomas were found in the liter-
ature during the last 40 years. Five cases were diagnosed as
AIDS-associated Kaposi’s sarcomas following maternal infec-
tion with human immunodeficiency virus [73–80].
Angiosarcoma
Only 5 gestational angiosarcomas were reported in the English
literature. Two were located to the breast and one to the skull.
No data are available for the other two patients [9,81–83].
Endometrial stromal sarcoma
Five cases (4%) have been reported between 2002 and 2014.
Most of them represent low-grade stromal sarcomas [85–89].Conclusions
In conclusion, diagnosis of bone and soft-tissue sarcomas in
young pregnant women is rare. However, almost all types of
sarcomas have been reported to coexist with pregnancy. In
localized disease the goal is to treat primarily the mother
and simultaneously to try to protect and safe the life of the
fetus depending on the period of gestation. In metastatic dis-
ease the prognosis of the mothers is still poor in majority of
the cases.
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